.png)
Influenza Diagnostics Market By Test Type And End User- Global Industry Analysis And Forecast To 2023
Published On : April 2018 Pages : 157 Category: Biotechnology Report Code : HC04719
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
The Influenza Diagnostics Market was worth USD billion in 2017 and is expected to reach approximately USD billion by 2023, while registering itself at a compound annual growth rate (CAGR) of % during the forecast period. Influenza or popularly known as ‘Flu’ is an infectious disease that is caused by any virus of influenza. Due to rising incidences of influenza the influenza diagnostic market is experiencing a growth in volume as well as value. The development in Investments for flu diagnostics, and rising interest for quicker diagnostics of influenza and control of flu are the central factors that are relied upon to drive the development of this market in the forecast years.
Test Type Outlook and Trend Analysis
According to the Type the market of Influenza Diagnostics is divided into Traditional and Molecular. The Traditional Test type is further divided into Traditional Viral Culture, Serology Test, Rapid Influenza Detection Test, and DFA. Rapid Influenza Detection Test (RIDT) constituted the major share of the market due to its benefits such as quick results, user friendly, etc. The RIDT is expected to continue growing during the forecast period. The Molecular test types segment is also further divided into Nucleic Acid Sequence-Based Amplification (NASBA), RT-PCR, Loop-Mediated Isothermal Amplification-Based Assays (LAMP), and Simple Amplification-Based Assays (SAMBA). Due to its ability to distinguish between Influenza A & B viruses the RT-PCR is the most widely used Molecular test.
End User Method Outlook and Trend Analysis
The End-User segment is fragmented into Hospitals & Clinics, Reference lab, POC, Home Care Agency. The Hospitals and Clinics segments amongst the End-User segments are prominent due to extensive use of these tests in diagnostics of influenza which are mostly carried out there.
Regional Outlook and Trend Analysis
According to the region, the Influenza Diagnostics Market is segmented as North America, Asia-Pacific, Europe and South America and Middle East & Africa. The Europe regions accounts to the majority of the share in the Influenza Diagnostics Market due to increasing population and also rising incidents of influenza diseases. The North-America region is the second largest market for Influenza Diagnostics followed by Asia-Pacific which is expected to grow at the highest CAGR during the forecast owing to increased expenditure, rising influenza incidents, etc.
Competitive Insights
The leading players in the market are Roche Diagnostics, Meridian Bioscience Inc., Becton, Abbott, QIAGEN, Alere Inc., Thermo Fisher Scientific Inc., and Dickinson & Company. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Influenza Diagnostics Market is segmented as follows-
By Natural Test Type:
- Traditional Viral Culture
- Serology Test
- Rapid Influenza Detection Test
- DFA
By Molecular Test Type:
- Nucleic Acid Sequence-Based Amplification (NASBA)
- RT-PCR
- Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
- Simple Amplification-Based Assays (SAMBA)
By End User:
- Hospital
- Clinic
- Reference lab
- POC
- Home Care Agency
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Influenza Diagnostics Market, By Traditional Test Type, Estimates and Forecast, 2014-2023 ($Million)
o Traditional Viral Culture
o Serology Test
o Rapid Influenza Detection Test
o DFA
· Influenza Diagnostics Market, By Molecular Test Type, Estimates and Forecast, 2014-2023 ($Million)
o Nucleic Acid Sequence-Based Amplification (NASBA)
o RT-PCR
o Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
o Simple Amplification-Based Assays (SAMBA)
· Influenza Diagnostics Market, By End User, Estimates and Forecast, 2014-2023 ($Million)
o Hospital
o Clinic
o Reference lab
o POC
o Home Care Agency
· Influenza Diagnostics Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
o North America
§ North America Influenza Diagnostics Market, By Country
o U.S. Influenza Diagnostics Market
o Canada Influenza Diagnostics Market
o Mexico Influenza Diagnostics Market
o Europe
§ Europe Influenza Diagnostics Market, By Country
o Germany Influenza Diagnostics Market
o UK Influenza Diagnostics Market
o France Influenza Diagnostics Market
o Russia Influenza Diagnostics Market
o Italy Influenza Diagnostics Market
o Rest of Europe Influenza Diagnostics Market
o Asia-Pacific
§ Asia-Pacific Influenza Diagnostics Market, By Country
o China Influenza Diagnostics Market
o Japan Influenza Diagnostics Market
o South Korea Influenza Diagnostics Market
o India Influenza Diagnostics Market
o Southeast Asia Influenza Diagnostics Market
o Rest of Asia-Pacific Influenza Diagnostics Market
o South America
§ South America Influenza Diagnostics Market
o Brazil Influenza Diagnostics Market
o Argentina Influenza Diagnostics Market
o Columbia Influenza Diagnostics Market
o South Africa Influenza Diagnostics Market
o Rest of South America Influenza Diagnostics Market
o Middle East and Africa
§ Middle East and Africa Influenza Diagnostics Market
o Saudi Arabia Influenza Diagnostics Market
o UAE Influenza Diagnostics Market
o Egypt Influenza Diagnostics Market
o Nigeria Influenza Diagnostics Market
o South Africa Influenza Diagnostics Market
o Rest of MEA Influenza Diagnostics Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing Incidents of Influenza
3.2.1.2. Increasing Investments in Influenza Diagnostics
3.2.1.3. Increasing Need for Faster Diagnostics of Influenza
3.2.2. Restraints
3.2.2.1. Variable Sensitivity of Influenza Diagnostics Tests
3.2.2.2. Stringent Regulations
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Influenza diagnostics Market, By Traditional Test Type
5.1. Introduction
5.2. Global Influenza diagnostics Revenue and Market Share By Traditional Test Type (2017-2027)
5.2.1. Global Influenza diagnostics Revenue and Revenue Share By Traditional Test Type (2017-2027)
5.3. Traditional Viral Culture
5.3.1. Global Traditional Viral Culture Revenue and Growth Rate (2017-2027)
5.4. Serology Test
5.4.1. Global Serology Test Revenue and Growth Rate (2017-2027)
5.5. Rapid Influenza Detection Test
5.5.1. Global Rapid Influenza Detection Test Revenue and Growth Rate (2017-2027)
5.6. DFA
5.6.1. Global DFA Revenue and Growth Rate (2017-2027)
6. Influenza diagnostics Market, By Molecular Test Type
6.1. Introduction
6.2. Global Influenza diagnostics Revenue and Market Share by Molecular Test Type (2017-2027)
6.2.1. Global Influenza diagnostics Revenue and Revenue Share by Molecular Test Type (2017-2027)
6.3. Nucleic Acid Sequence-Based Amplification (NASBA)
6.3.1. Global Nucleic Acid Sequence-Based Amplification (NASBA) Revenue and Growth Rate (2017-2027)
6.4. RT-PCR
6.4.1. Global RT-PCR Revenue and Growth Rate (2017-2027)
6.5. Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
6.5.1. Global Loop-Mediated Isothermal Amplification-Based Assays (LAMP) Revenue and Growth Rate (2017-2027)
6.6. Simple Amplification-Based Assays (SAMBA)
6.6.1. Global Simple Amplification-Based Assays (SAMBA) Revenue and Growth Rate (2017-2027)
7. Influenza diagnostics Market, By End User
7.1. Introduction
7.2. Global Influenza diagnostics Revenue and Market Share by End User (2017-2027)
7.2.1. Global Influenza diagnostics Revenue and Revenue Share by End User (2017-2027)
7.3. Hospital
7.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
7.4. Clinic
7.4.1. Global Clinic Revenue and Growth Rate (2017-2027)
7.5. Reference lab
7.5.1. Global Reference lab Revenue and Growth Rate (2017-2027)
7.6. POC
7.6.1. Global POC Revenue and Growth Rate (2017-2027)
7.7. Home Care Agency
7.7.1. Global Home Care Agency Revenue and Growth Rate (2017-2027)
8. Influenza diagnostics Market, By Region
8.1. Introduction
8.2. Global Influenza diagnostics Revenue and Market Share by Regions
8.2.1. Global Influenza diagnostics Revenue by Regions (2017-2027)
8.3. North America Influenza diagnostics by Countries
8.3.1. North America Influenza diagnostics Revenue and Growth Rate (2017-2027)
8.3.2. North America Influenza diagnostics Revenue by Countries (2017-2027)
8.3.3. North America Influenza diagnostics Revenue (Million USD) by Countries (2017-2027)
8.3.4. U.S.
8.3.4.1. United States Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Canada
8.3.5.1. Canada Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Mexico
8.3.6.1. Mexico Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Influenza diagnostics by Countries
8.4.1. Europe Influenza diagnostics Revenue and Growth Rate (2017-2027)
8.4.2. Europe Influenza diagnostics Revenue by Countries (2017-2027)
8.4.3. Europe Influenza diagnostics Revenue (Million USD) by Countries (2017-2027)
8.4.4. Germany
8.4.4.1. Germany Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. France
8.4.6.1. France Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Russia
8.4.7.1. Russia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Italy
8.4.8.1. Italy Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Rest of Europe
8.4.9.1. Rest of Europe Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Influenza diagnostics Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Influenza diagnostics Revenue by Countries (2017-2027)
8.5.3. Asia-Pacific Influenza diagnostics Revenue (Million USD) by Countries (2017-2027)
8.5.4. China
8.5.4.1. China Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Japan
8.5.5.1. Japan Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5.2.
8.5.6. Korea
8.5.6.1. Korea Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. India
8.5.7.1. India Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Southeast Asia
8.5.8.1. Southeast Asia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Rest of Asia-Pacific
8.5.9.1. Rest of Asia-Pacific Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Influenza diagnostics Revenue and Growth Rate (2017-2027)
8.6.2. South America Influenza diagnostics Revenue by Countries (2017-2027)
8.6.3. South America Influenza diagnostics Revenue (Million USD) by Countries (2017-2027)
8.6.4. Brazil
8.6.4.1. Brazil Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Argentina
8.6.5.1. Argentina Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Columbia
8.6.6.1. Columbia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Rest of South America
8.6.7.1. Rest of South America Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Influenza diagnostics Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Influenza diagnostics Revenue by Countries (2017-2027)
8.7.3. Middle East and Africa Influenza diagnostics Revenue (Million USD) by Countries (2017-2027)
8.7.4. Saudi Arabia
8.7.4.1. Saudi Arabia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. United Arab Emirates
8.7.5.1. United Arab Emirates Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Egypt
8.7.6.1. Egypt Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Nigeria
8.7.7.1. Nigeria Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. South Africa
8.7.8.1. South Africa Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Roche Diagnostics
9.1.1. Business Overview
9.1.2. Types Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Meridian Bioscience Inc
9.2.1. Business Overview
9.2.2. Types Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Becton
9.3.1. Business Overview
9.3.2. Types Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Abbott
9.4.1. Business Overview
9.4.2. Types Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. QIAGEN
9.5.1. Business Overview
9.5.2. Types Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Alere Inc.
9.6.1. Business Overview
9.6.2. Types Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Thermo Fisher Scientific Inc.
9.7.1. Business Overview
9.7.2. Types Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Dickinson & Company
9.8.1. Business Overview
9.8.2. Types Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
10. Global Influenza diagnostics Market Competition, by Manufacturer
10.1. Global Influenza diagnostics Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Influenza diagnostics Price by Region (2017-2017)
10.3. Top 5 Influenza diagnostics Manufacturer Market Share
10.4. Market Competition Trend
11. Influenza diagnostics Market Forecast (2027-2023)
11.1. Global Influenza diagnostics Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Influenza diagnostics Market Forecast by Regions (2027-2023)
11.2.1. North America Influenza diagnostics Market Forecast (2027-2023)
11.2.1.1. United States Influenza diagnostics Market Forecast (2027-2023)
11.2.1.2. Canada Influenza diagnostics Market Forecast (2027-2023)
11.2.1.3. Mexico Influenza diagnostics Market Forecast (2027-2023)
11.2.2. Europe Influenza diagnostics Market Forecast (2027-2023)
11.2.2.1. Germany Influenza diagnostics Market Forecast (2027-2023)
11.2.2.2. United Kingdom Influenza diagnostics Market Forecast (2027-2023)
11.2.2.3. France Influenza diagnostics Market Forecast (2027-2023)
11.2.2.4. Russia Influenza diagnostics Market Forecast (2027-2023)
11.2.2.5. Italy Influenza diagnostics Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Influenza diagnostics Market Forecast (2027-2023)
11.2.3. Asia-Pacific Influenza diagnostics Market Forecast (2027-2023)
11.2.3.1. China Influenza diagnostics Market Forecast (2027-2023)
11.2.3.2. Japan Influenza diagnostics Market Forecast (2027-2023)
11.2.3.3. Korea Influenza diagnostics Market Forecast (2027-2023)
11.2.3.4. India Influenza diagnostics Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Influenza diagnostics Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Influenza diagnostics Market Forecast (2027-2023)
11.2.4. South America Influenza diagnostics Market Forecast (2027-2023)
11.2.4.1. Brazil Influenza diagnostics Market Forecast (2027-2023)
11.2.4.2. Argentina Influenza diagnostics Market Forecast (2027-2023)
11.2.4.3. Columbia Influenza diagnostics Market Forecast (2027-2023)
11.2.4.4. Rest of South America Influenza diagnostics Market Forecast (2027-2023)
11.2.5. Middle East and Africa Influenza diagnostics Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Influenza diagnostics Market Forecast (2027-2023)
11.2.5.2. UAE Influenza diagnostics Market Forecast (2027-2023)
11.2.5.3. Egypt Influenza diagnostics Market Forecast (2027-2023)
11.2.5.4. Nigeria Influenza diagnostics Market Forecast (2027-2023)
11.2.5.5. South Africa Influenza diagnostics Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Influenza diagnostics Market Forecast (2027-2023)
11.3. Influenza diagnostics Market Forecast By Traditional Test Type (2027-2023)
11.3.1. Global Influenza diagnostics Revenue Forecast By Traditional Test Type (2027-2023)
11.3.2. Global Influenza diagnostics Revenue Market Share Forecast By Traditional Test Type (2027-2023)
11.4. Influenza diagnostics Market Forecast by Molecular Test Type (2027-2023)
11.4.1. Global Influenza diagnostics Revenue Forecast by Molecular Test Type (2027-2023)
11.4.2. Global Influenza diagnostics Revenue Market Share Forecast by Molecular Test Type (2027-2023)
11.5. Influenza diagnostics Market Forecast by End User (2027-2023)
11.5.1. Global Influenza diagnostics Revenue Forecast by End User (2027-2023)
11.5.2. Global Influenza diagnostics Revenue Market Share Forecast by End User (2027-2023)
List of Tables
12. List of Tables and Figures
Figure United States Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Canada Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Mexico Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Germany Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure France Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure UK Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Russia Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Italy Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure China Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Japan Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Korea Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure India Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Southeast Asia Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Brazil Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Egypt Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Saudi Arabia Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure South Africa Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Figure Nigeria Influenza diagnostics Revenue (Million USD) and Growth Rate (2017-2023)
Table Global Influenza diagnostics Revenue and Revenue Share By Traditional Test Type (2017-2018)
Figure Global Traditional Viral Culture Revenue and Growth Rate (2017-2018)
Figure Global Serology Test Revenue and Growth Rate (2017-2018)
Figure Global Rapid Influenza Detection Test Revenue and Growth Rate (2017-2018)
Figure Global DFA Revenue and Growth Rate (2017-2018)
Table Global Influenza diagnostics Revenue and Revenue Share by Molecular Test Type (2017-2018)
Figure Global Nucleic Acid Sequence-Based Amplification (NASBA) Revenue and Growth Rate (2017-2018)
Figure Global RT-PCR Revenue and Growth Rate (2017-2018)
Figure Global Loop-Mediated Isothermal Amplification-Based Assays (LAMP) Revenue and Growth Rate (2017-2018)
Figure Global Simple Amplification-Based Assays (SAMBA) Revenue and Growth Rate (2017-2018)
Table Global Influenza diagnostics Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Reference lab Revenue and Growth Rate (2017-2018)
Figure Global POC Revenue and Growth Rate (2017-2018)
Figure Global Home Care Agency Revenue and Growth Rate (2017-2018)
Table Global Influenza diagnostics Revenue by Regions (2017-2018)
Figure North America Influenza diagnostics Revenue and Growth Rate (2017-2018)
Table North America Influenza diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure United States Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Influenza diagnostics Revenue and Growth Rate (2017-2018)
Table Europe Influenza diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Influenza diagnostics Revenue and Growth Rate (2017-2018)
Table Asia-Pacific Influenza diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure China Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Influenza diagnostics Revenue and Growth Rate (2017-2018)
Table South America Influenza diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Influenza diagnostics Revenue and Growth Rate (2017-2018)
Table Middle East and Africa Influenza diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Influenza diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Roche Diagnostics Revenue and Market Share (2017-2017)
Table Meridian Bioscience Inc. Revenue and Market Share (2017-2017)
Table Becton Revenue and Market Share (2017-2017)
Table Abbott Revenue and Market Share (2017-2017)
Table QIAGEN Revenue and Market Share (2017-2017)
Table Alere Inc Revenue and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc Revenue and Market Share (2017-2017)
Table Dickinson & Company Revenue and Market Share (2017-2017)
Figure Global Influenza diagnostics Revenue and Market Share by Manufacturer
Table Global Influenza diagnostics Price by Region (2017-2017)
Figure Top 5 Influenza diagnostics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Influenza diagnostics Revenue (Millions USD) and Growth Rate (2018-2023)
Table Influenza diagnostics Market Forecast by Regions (2018-2023)
Figure North America Influenza diagnostics Market Forecast (2018-2023)
Figure United States Influenza diagnostics Market Forecast (2018-2023)
Figure Canada Influenza diagnostics Market Forecast (2018-2023)
Figure Mexico Influenza diagnostics Market Forecast (2018-2023)
Figure Europe Influenza diagnostics Market Forecast (2018-2023)
Figure Germany Influenza diagnostics Market Forecast (2018-2023)
Figure United Kingdom Influenza diagnostics Market Forecast (2018-2023)
Figure France Influenza diagnostics Market Forecast (2018-2023)
Figure Russia Influenza diagnostics Market Forecast (2018-2023)
Figure Italy Influenza diagnostics Market Forecast (2018-2023)
Figure Asia-Pacific Influenza diagnostics Market Forecast (2018-2023)
Figure China Influenza diagnostics Market Forecast (2018-2023)
Figure Japan Influenza diagnostics Market Forecast (2018-2023)
Figure Korea Influenza diagnostics Market Forecast (2018-2023)
Figure India Influenza diagnostics Market Forecast (2018-2023)
Figure Southeast Asia Influenza diagnostics Market Forecast (2018-2023)
Figure Rest of Asia-Pacific Influenza diagnostics Market Forecast (2018-2023)
Figure South America Influenza diagnostics Market Forecast (2018-2023)
Figure Brazil Influenza diagnostics Market Forecast (2018-2023)
Figure Argentina Influenza diagnostics Market Forecast (2018-2023)
Figure Columbia Influenza diagnostics Market Forecast (2018-2023)
Figure Rest of South America Influenza diagnostics Market Forecast (2018-2023)
Figure Middle East and Africa Influenza diagnostics Market Forecast (2018-2023)
Figure Saudi Arabia Influenza diagnostics Market Forecast (2018-2023)
Figure UAE Influenza diagnostics Market Forecast (2018-2023)
Figure Egypt Influenza diagnostics Market Forecast (2018-2023)
Figure Nigeria Influenza diagnostics Market Forecast (2018-2023)
Figure South Africa Influenza diagnostics Market Forecast (2018-2023)
Figure Rest of MEA Influenza diagnostics Market Forecast (2018-2023)
Figure Global Influenza diagnostics Revenue Forecast By Traditional Test Type (2018-2023)
Figure Global Influenza diagnostics Revenue Market Share Forecast By Traditional Test Type (2018-2023)
Figure Global Influenza diagnostics Revenue Forecast by Molecular Test Type (2018-2023)
Figure Global Influenza diagnostics Revenue Market Share Forecast by Molecular Test Type (2018-2023)
Figure Global Influenza diagnostics Revenue Forecast by End User (2018-2023)
Figure Global Influenza diagnostics Revenue Market Share Forecast by End User (2018-2023)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|